AstraZeneca gets another approval for 'Forxiga'
9th Aug 2021 07:35
(Sharecast News) - AstraZeneca announced on Monday that 'Forxiga', or dapagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, has been approved in the European Union for the treatment of chronic kidney disease (CKD) in adults with and without type-2 diabetes.
Read moreAstraZeneca's Saphnelo receives FDA approval
2nd Aug 2021 08:07
(Sharecast News) - Drugmaker AstraZeneca said on Monday that Saphnelo had been approved in the US for the treatment of adult patients already receiving standard therapy for moderate to severe systemic lupus erythematosus.
Read moreAstraZeneca boss not yet sure if booster shots will be needed
29th Jul 2021 14:48
(Sharecast News) - AstraZeneca does not know yet whether so-called 'booster' shots of its Covid-19 vaccine will be needed or not.
Read moreAstraZeneca lifts EPS guidance as H1 revenues jump
29th Jul 2021 08:07
(Sharecast News) - AstraZeneca posted a jump in first-half revenue on Thursday as it updated its guidance to include recently-acquired Alexion Pharmaceuticals.
Read moreIMF calls for rapid action to increase access to Covid-19 vaccines
27th Jul 2021 15:19
(Sharecast News) - The International Monetary Fund's chief economist called on world governments to improve low-and-middle income countries' access to vaccines in order to avoid downside risks.
Read moreAstraZeneca's 'Ultomiris' gets EU approval for use in children
26th Jul 2021 07:25
(Sharecast News) - AstraZeneca said on Monday that 'Ultomiris', or ravulizumab, has been recommended for marketing authorisation in the European Union for expanded use, to include children and adolescents with paroxysmal nocturnal haemoglobinuria (PNH).
Read moreJefferies believes Delta may be less lethal than other variants
20th Jul 2021 09:42
(Sharecast News) - Analysts at Jefferies believe the so-called Delta variant may be less lethal, even if more transmissible, than earlier variants of the virus.
Read moreAstraZeneca lung cancer drug approved in China
19th Jul 2021 07:52
(Sharecast News) - Pharmaceutical company AstraZeneca said its drug to treat extensive-stage small cell lung cancer had been approved in China.
Read moreFDA Committee votes against AstraZeneca anaemia treatment
16th Jul 2021 08:03
(Sharecast News) - AstraZeneca said on Friday that the US Food and Drug Administration has voted against the use of its roxadustat drug for the treatment of anaemia in chronic kidney disease in non-dialysis dependent (NDD) and dialysis-dependent (DD) adults.
Read moreCMA clears AstraZeneca's $39bn Alexion acquisition
14th Jul 2021 07:32
(Sharecast News) - AstraZeneca said on Wednesday that its proposed $39bn acquisition of US drug developer Alexion is expected to close on 21 July, after receiving clearance from the UK Competition and Markets Authority.
Read moreThursday broker round-up
8th Jul 2021 13:04
(Sharecast News) - Croda International: HSBC upgrades to buy with a target price of 8,600p.
Read moreAstraZeneca asthma drug gets priority FDA review
8th Jul 2021 07:39
(Sharecast News) - AstraZeneca on Thursday said its experimental drug tezepelumab had been given a priority review by the US Food and Drug Administration for potential approval as a treatment for asthma.
Read moreAstraZeneca's Alexion acquisition cleared by European Commission
6th Jul 2021 07:44
(Sharecast News) - AstraZeneca said on Tuesday that its $39bn proposed acquisition of US drug developer Alexion has been cleared by the European Commission.
Read moreGermany advised to combine AstraZeneca and mRNA vaccines to brake Delta variant
2nd Jul 2021 11:17
(Sharecast News) - Germany's government committee on vaccinations believes combining the Covid-19 vaccine made by AstraZeneca and mRNA ones such as Pfizer's is the best way to combat the so-called Delta variant.
Read moreJohnson and Johnson Covid-19 shot effective against Delta variant
2nd Jul 2021 08:04
(Sharecast News) - Johnson&Johnson's Covid-19 vaccine provides protections against all variants, including the increasingly predominant Delta variant.
Read more